Cargando…
Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based Therapies
The breakthrough in human induced pluripotent stem cells (hiPSCs) has revolutionized the field of biomedical and pharmaceutical research and opened up vast opportunities for drug discovery and regenerative medicine, especially when combined with gene-editing technology. Numerous healthy and patient-...
Autores principales: | Pratumkaew, Ponthip, Issaragrisil, Surapol, Luanpitpong, Sudjit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623953/ https://www.ncbi.nlm.nih.gov/pubmed/34831472 http://dx.doi.org/10.3390/cells10113250 |
Ejemplares similares
-
Generation and Functional Characterization of Anti-CD19 Chimeric Antigen Receptor-Natural Killer Cells from Human Induced Pluripotent Stem Cells
por: Klaihmon, Phatchanat, et al.
Publicado: (2023) -
Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells
por: Klaihmon, Phatchanat, et al.
Publicado: (2023) -
Selective Cytotoxicity of Single and Dual Anti-CD19 and Anti-CD138 Chimeric Antigen Receptor-Natural Killer Cells against Hematologic Malignancies
por: Luanpitpong, Sudjit, et al.
Publicado: (2021) -
Role of YAP in hematopoietic differentiation and erythroid lineage specification of human-induced pluripotent stem cells
por: Laowtammathron, Chuti, et al.
Publicado: (2023) -
A novel E-cadherin/SOX9 axis regulates cancer stem cells in multiple myeloma by activating Akt and MAPK pathways
por: Samart, Parinya, et al.
Publicado: (2022)